Lykera Biomed

Monoclonal antibodies (MAbs) as therapy for solid tumors

placeBarcelona, Catalonia, Spain calendar_todayFounded 2010 groups1 employees language lykerabiomed.com

2 investors on record.

Investor type	Count	Share
Venture capital	2	100%

Coming soon